Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Pharmacogenomics of Interferon-ß Therapy in Multiple Sclerosis: Baseline IFN Signature Determines Pharmacological Differences between Patients

  • Lisa G. M. van Baarsen ,

    Contributed equally to this work with: Lisa G. M. van Baarsen, Saskia Vosslamber

    Affiliations Department of Molecular Cell Biology and Immunology, VU Medical Center, Amsterdam, The Netherlands, Department of Pathology, VU Medical Center, Amsterdam, The Netherlands

  • Saskia Vosslamber ,

    Contributed equally to this work with: Lisa G. M. van Baarsen, Saskia Vosslamber

    Affiliations Department of Molecular Cell Biology and Immunology, VU Medical Center, Amsterdam, The Netherlands, Department of Pathology, VU Medical Center, Amsterdam, The Netherlands

  • Marianne Tijssen,

    Affiliation Department of Pathology, VU Medical Center, Amsterdam, The Netherlands

  • Josefien M. C. Baggen,

    Affiliation Department of Molecular Cell Biology and Immunology, VU Medical Center, Amsterdam, The Netherlands

  • Laura F. van der Voort,

    Affiliation Department of Neurology, VU Medical Center, Amsterdam, The Netherlands

  • Joep Killestein,

    Affiliation Department of Neurology, VU Medical Center, Amsterdam, The Netherlands

  • Tineke C. T. M. van der Pouw Kraan,

    Affiliation Department of Molecular Cell Biology and Immunology, VU Medical Center, Amsterdam, The Netherlands

  • Chris H. Polman,

    Affiliation Department of Neurology, VU Medical Center, Amsterdam, The Netherlands

  • Cornelis L. Verweij

    c.verweij@vumc.nl

    Affiliations Department of Molecular Cell Biology and Immunology, VU Medical Center, Amsterdam, The Netherlands, Department of Pathology, VU Medical Center, Amsterdam, The Netherlands

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.